While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...

BioAFM is seeing increasingly widespread use in biomedical and biological studies due to its extremely high resolution and ...

Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Bruker Co. (NASDAQ:BRKR – Free Report) – Stock analysts at Zacks Research upped their FY2027 EPS estimates for shares of Bruker in a report issued on Tuesday, March 11th. Zacks Research analyst R.

The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...

Bruker Spatial Biology will announce the following four innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering, best-in-class platforms: The Whole ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: ...

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025.